BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,092 filers reported holding BAXTER INTL INC in Q1 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $207 | -26.3% | 5,479 | -11.1% | 0.05% | -9.6% |
| Q2 2023 | $281 | +12.0% | 6,163 | 0.0% | 0.05% | +4.0% |
| Q1 2023 | $251 | -19.8% | 6,163 | +0.2% | 0.05% | -23.1% |
| Q4 2022 | $313 | -99.9% | 6,149 | -0.0% | 0.06% | -11.0% |
| Q3 2022 | $332,000 | -19.8% | 6,150 | -4.4% | 0.07% | -11.0% |
| Q2 2022 | $414,000 | -39.3% | 6,436 | -26.8% | 0.08% | -2.4% |
| Q1 2022 | $682,000 | -29.1% | 8,792 | -21.5% | 0.08% | +12.0% |
| Q4 2021 | $962,000 | -21.9% | 11,207 | -26.7% | 0.08% | -18.5% |
| Q3 2021 | $1,231,000 | -2.5% | 15,299 | -2.4% | 0.09% | +2.2% |
| Q2 2021 | $1,262,000 | -17.8% | 15,682 | -13.9% | 0.09% | -15.1% |
| Q1 2021 | $1,536,000 | +7.3% | 18,212 | +2.1% | 0.11% | -3.6% |
| Q4 2020 | $1,431,000 | +7.9% | 17,836 | +8.1% | 0.11% | -14.1% |
| Q3 2020 | $1,326,000 | -15.8% | 16,498 | -9.8% | 0.13% | -14.1% |
| Q2 2020 | $1,575,000 | +37.8% | 18,291 | +30.0% | 0.15% | +1.4% |
| Q1 2020 | $1,143,000 | -3.0% | 14,067 | +6.4% | 0.15% | +17.6% |
| Q4 2019 | $1,178,000 | +3.1% | 13,217 | -11.3% | 0.12% | +5.9% |
| Q3 2019 | $1,143,000 | +0.4% | 14,895 | +10.0% | 0.12% | -4.8% |
| Q2 2019 | $1,138,000 | +0.2% | 13,545 | -3.1% | 0.12% | -1.6% |
| Q1 2019 | $1,136,000 | +17.7% | 13,974 | -4.7% | 0.13% | +53.7% |
| Q4 2018 | $965,000 | +5.5% | 14,664 | +0.1% | 0.08% | +12.3% |
| Q3 2018 | $915,000 | -21.2% | 14,645 | -6.8% | 0.07% | -13.1% |
| Q2 2018 | $1,161,000 | -14.6% | 15,707 | -24.9% | 0.08% | -7.7% |
| Q1 2018 | $1,360,000 | +0.1% | 20,907 | -0.6% | 0.09% | +2.2% |
| Q4 2017 | $1,359,000 | -0.4% | 21,023 | -3.4% | 0.09% | -2.2% |
| Q3 2017 | $1,365,000 | +4.6% | 21,753 | +1.2% | 0.09% | +1.1% |
| Q2 2017 | $1,305,000 | +26.9% | 21,494 | +8.7% | 0.09% | +26.8% |
| Q1 2017 | $1,028,000 | -99.9% | 19,771 | +9.1% | 0.07% | -19.3% |
| Q4 2016 | $804,000,000 | – | 18,123 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 41,000,000 | $2,482,140,000 | 22.00% |
| THUNDERBIRD PARTNERS LLP | 1,711,643 | $103,623,000 | 12.17% |
| SECTOR GAMMA AS | 1,070,333 | $64,798,000 | 9.42% |
| Veritas Asset Management LLP | 10,179,102 | $616,243,000 | 4.81% |
| 13D Management LLC | 194,807 | $11,794,000 | 4.18% |
| Progressive Investment Management Corp | 78,316 | $4,741,000 | 3.69% |
| Aristotle Capital Management, LLC | 6,846,307 | $414,476,000 | 3.46% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,394,075 | $84,397,000 | 3.37% |
| Lipe & Dalton | 80,073 | $4,848,000 | 3.14% |
| PURA VIDA INVESTMENTS, LLC | 125,000 | $7,568,000 | 3.00% |